GTG the next, page-7

Just remember its not just China, that we looking for confidence. 

But India, binding agreement with Omix Ventures Private Ltd, also known as Shivom. Its able to provide Genetic Technologies with access to large pools of data in relation to the Indian population, allowing it to conduct new tests related to diabetes and other diseases.

Are money booter, is GTG is committed to actively developing a range of risk prediction tests, not 5% or 10% but 100% that are designed to assist in the early detection of diseases and help physicians improve patient outcomes. 

Blockchain technology presents a unique opportunity for GTG to contribute to the advancement of cancer and other disease research

Imo This IPO will skyrocket short and long term, once ann gets realsesd. It's revolutional.

from the ann: For perspective, there are 17.7 million deaths per annum due to cardiovascular disease, 8.2 million deaths per annum due to cancer and 1.6 million deaths per annum due to diabetes. (Source: World Health Organisation).